Press Releases
August 03, 2022
First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
June 28, 2022
CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction
June 23, 2022